» Articles » PMID: 35565655

Does Mediterranean Adequacy Index Correlate with Cardiovascular Events in Patients with Advanced Chronic Kidney Disease? An Exploratory Study

Overview
Journal Nutrients
Date 2022 May 14
PMID 35565655
Authors
Affiliations
Soon will be listed here.
Abstract

The Mediterranean Diet (MD) is a healthy dietary pattern, demonstrated to reduce the risk of cancer, diabetes, cardiovascular and neurodegenerative diseases, and early death. The Mediterranean Adequacy Index (MAI) is used to measure adherence to the MD in perspective studies in the general population and correlates with cardiovascular events. The aim of this study was to calculate the MAI among patients with advanced chronic kidney disease (CKD) and correlate it with traditional uremic, microbiota-derived, and proatherogenic toxins as well as nutritional status, quality of life, and cardiovascular events. A total of 60 adult patients with advanced CKD were enrolled and their MAI was calculated. According to the median value, patients were divided into lower (l-MAI, <1.80) and higher (h-MAI, ≥1.80) MAI groups. Biochemical parameters, microbiota-derived and proatherogenic toxins (p-Cresyl sulphate, Indoxyl-sulphate, and Lipoprotein-associated phospholipase A2), nutritional status, quality of life, and cardiovascular events that occurred in the previous three years were recorded. The mean value of the MAI was 2.78 ± 2.86. The MAI was significantly higher in foreigners (median (IQR) 6.38 (8.98) vs. 1.74 (1.67), p < 0.001) and diabetic patients. The l-MAI and h-MAI groups had similar routinary blood, p-Cresyl-sulphate, Indoxyl-sulphate, and Lp-PLA2 as well as nutritional status and quality of life parameters. The MAI was not associated with previous cardiovascular events and did not correlate with cardiovascular events in CKD patients. New and nephro-tailored indexes are warranted to evaluate nutritional therapy in CKD patients.

Citing Articles

Pea hull fiber supplementation does not modulate uremic metabolites in adults receiving hemodialysis: a randomized, double-blind, controlled trial.

Fatani A, Suh J, Auger J, Alabasi K, Wang Y, Segal M Front Nutr. 2023; 10:1179295.

PMID: 37457968 PMC: 10349378. DOI: 10.3389/fnut.2023.1179295.

References
1.
Cukor D, Fruchter Y, Ver Halen N, Naidoo S, Patel A, Saggi S . A preliminary investigation of depression and kidney functioning in patients with chronic kidney disease. Nephron Clin Pract. 2013; 122(3-4):139-45. DOI: 10.1159/000349940. View

2.
Dinu M, Pagliai G, Casini A, Sofi F . Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr. 2017; 72(1):30-43. DOI: 10.1038/ejcn.2017.58. View

3.
da Silva R, Bach-Faig A, Raido Quintana B, Buckland G, de Almeida M, Serra-Majem L . Worldwide variation of adherence to the Mediterranean diet, in 1961-1965 and 2000-2003. Public Health Nutr. 2009; 12(9A):1676-84. DOI: 10.1017/S1368980009990541. View

4.
Andersen J, Rowland B, Gloster E, Willis D, Hernandez N, Felix H . Associations among Self-Reported Mental Health, Physical Activity, and Diet during the COVID-19 Pandemic. Nutr Health. 2022; 28(4):711-719. PMC: 8891903. DOI: 10.1177/02601060221082362. View

5.
Vanstone M, Giacomini M, Smith A, Brundisini F, Dejean D, Winsor S . How diet modification challenges are magnified in vulnerable or marginalized people with diabetes and heart disease: a systematic review and qualitative meta-synthesis. Ont Health Technol Assess Ser. 2013; 13(14):1-40. PMC: 3817924. View